November 21st 2024
Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.
McAneny Discusses OCM, Community Practices, and Building the Right Rewards
December 10th 2018The American Journal of Managed Care® sat down with Barbara McAneny, MD, president of the American Medical Association (AMA), to discuss how the AMA is working to "help create the healthcare system of the future."
Read More
Cancer Today and Cancer Tomorrow: Analysis of US Cancer Claims, 2007-2017
December 10th 2018In this article, we use data from our FAIR Health database of over 27 billion privately billed healthcare claims to identify the cancer diagnosis categories with the highest percentage of claim lines among all cancer diagnosis categories.
Read More
Dr Lawrence Shulman Discusses Pathways and Improvements in Breast Cancer Treatment
December 8th 2018Improvements in treatments have led to less toxicities and better quality of life for patients with breast cancer, said Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania.
Watch
Renting Health vs Buying Cures: How New Financing Tools Can Boost Cancer Therapy Development
December 7th 2018Evidence-Based OncologyTM sat down with Andrew W. Lo, PhD, to discuss his proposals to increase investment in medical innovation and utilization by giving investors more ways to support both research organizations and individual patients.
Read More
Beth Wittmer on Keeping Patients With Neutropenia Out of the Emergency Department
December 7th 2018Informing patients about what to look for with neutropenia can help keep them out of the emergency department (ED) so they can be treated in the clinic, instead, said Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Watch
Dr Sibel Blau Outlines Changes to Her Practice to Prepare for OCM
December 6th 2018Years before the Oncology Care Model (OCM) was implemented, Northwest Medical Specialties started preparing by making changes to the personnel in the practice, explained Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Watch
Dr Thorvardur Halfdanarson Discusses Lack of Risk Factors, Biomarkers in NETs
December 4th 2018There is a lot of disagreement, even within the neuroendocrine tumor (NET) circles, that there are biomarkers that predict outcomes and some that may even predict responses to therapy, explained Thorvardur Halfdanarson, MD, associate professor of medicine and consultant in medical oncology, Mayo Clinic.
Watch